Casdin Capital, LLC Portfolio Holdings

Casdin Capital, LLC

  • $855 Million
  • Q1 2025

Casdin Capital, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $855 Million distributed in 44 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Biolife Solutions Inc with a value of $199M, Revolution Medicines, Inc. with a value of $131M, Standard Biotools Inc. with a value of $82.2M, Avidity Biosciences, Inc. with a value of $60.4M, and Sarepta Therapeutics, Inc. with a value of $57.5M.

Examining the 13F form we can see an decrease of $307M in the current position value, from $1.16B to 855M.

Casdin Capital, LLC is based out at New York, NY

Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $855 Million
Healthcare: $848 Million
Consumer Defensive: $5.91 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$930M
$199 Million 23.27% of portfolio
8,707,165
Q4 2023 Added 11.92%
$3.49B
$131 Million 15.3% of portfolio
3,697,933
Q1 2025 Reduced 0.04%
$72.4M
$82.2 Million 9.61% of portfolio
76,075,636
Q1 2025 Added 6.77%
$1.59B
$60.4 Million 7.06% of portfolio
2,045,000
Q4 2024 Reduced 1.91%
$3.32B
$57.5 Million 6.73% of portfolio
900,783
Q1 2025 Reduced 16.09%
$12.6B
$47.2 Million 5.52% of portfolio
595,000
Q1 2025 Reduced 20.67%
$35.7B
$32.4 Million 3.79% of portfolio
120,000
Q1 2025 Reduced 14.29%
$6.06B
$28.9 Million 3.38% of portfolio
326,378
Q4 2023 Reduced 12.12%
$1.18B
$27.8 Million 3.26% of portfolio
1,425,562
Q1 2025 Added 14.04%
$350M
$23.8 Million 2.79% of portfolio
9,098,574
Q1 2025 Added 1.68%
$157M
$21.8 Million 2.55% of portfolio
8,100,000
Q3 2024 Added 305.0%
$261M
$18.3 Million 2.14% of portfolio
3,995,571
Q3 2024 Added 30.61%
$10.1B
$17.5 Million 2.05% of portfolio
405,000
Q1 2025 Reduced 37.69%
$696M
$14.2 Million 1.66% of portfolio
2,000,000
Q2 2024 Added 6.67%
$1.8B
$13.5 Million 1.58% of portfolio
990,000
Q3 2024 Reduced 23.85%
$3.88B
$10.7 Million 1.25% of portfolio
250,000
Q1 2025 Reduced 28.57%
$23.5B
$9.07 Million 1.06% of portfolio
40,000
Q1 2025 New
$1.94B
$8.19 Million 0.96% of portfolio
276,308
Q4 2024 Reduced 58.53%
$557M
$7.8 Million 0.91% of portfolio
635,000
Q1 2025 Added 33.68%
$1.63B
$7.33 Million 0.86% of portfolio
250,000
Q4 2024 New
$10.3B
$6.38 Million 0.75% of portfolio
225,000
Q1 2025 Added 28.57%
$10.9B
$5.91 Million 0.69% of portfolio
200,000
Q1 2025 New
$18.2M
$3.84 Million 0.45% of portfolio
6,732,971
Q1 2024 Added 5.51%
$252M
$2.44 Million 0.29% of portfolio
973,260
Q3 2023 Reduced 28.87%
$1.1B
$2.39 Million 0.28% of portfolio
300,000
Q1 2025 New
$33M
$1.54 Million 0.18% of portfolio
3,212,316
Q1 2025 Reduced 38.11%
$622M
$1.05 Million 0.12% of portfolio
100,000
Q1 2025 New
$207M
$854,000 0.1% of portfolio
723,767
Q1 2025 Reduced 30.13%
$736M
$874,000 0.1% of portfolio
165,323
Q4 2024 New
$123M
$730,000 0.09% of portfolio
367,175
Q2 2023 Reduced 50.0%
$185M
$399,000 0.05% of portfolio
86,014
Q3 2024 Reduced 67.05%
$182M
$171,000 0.02% of portfolio
125,000
Q1 2025 Reduced 89.48%
$38.6M
$101,000 0.01% of portfolio
123,839
Q2 2022 Reduced 78.77%
Verastem Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 50.0%
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q1 2025 New
Genedx Holdings Corp
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.55%
Ginkgo Bioworks Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 37.32%
Maze Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Solid Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Neurogene Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 146.92%
Septerna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 44
  • Current Value $855 Million
  • Prior Value $1.16 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 8 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email